Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03522324 · ClinicalTrials.gov registry record
Pain Research: Innovative Strategies With Marijuana
A clinical trial, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- 268
- Enrollment target
NCT03522324: Completed study, sponsored by University of Colorado, Boulder.
NCT03522324 is a clinical trial that has completed, run by University of Colorado, Boulder. The registered enrollment target is 268 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03522324 has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- 268 participants
- Enrollment target
Study Summary
This study tests the effects of cannabinoid levels in blood on pain relief, inflammation, and cognitive dysfunction in chronic pain patients who choose to use edible cannabis. Over a two-week period, participants use an edible product of their choice. Blood levels of 9-delta-tetrahydrocannabinol (THC) and cannabidiol (CBD) will be measured before, during, and after the two-week exposure period to determine whether there are associations with pain, inflammation, sleep, physical activity, anxiety/depression, and cognitive dysfunction. After the two-week self-administration period, participants will be followed for six months to collect self-report data on cannabis use, pain levels, sleep quality, and mental health symptoms.
Primary Outcome
The Roland Morris Disability Questionnaire assesses self-rated physical disability caused by low back pain. Scores range from 0 to 24, with higher scores indicating more pain interference.
Interventions
- DRUG Cannabis Edible
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2023-10-12 |
What the finished NCT03522324 record still lists
NCT03522324 is an observational study that tracks outcomes without assigning an intervention. The registered 268 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Cannabis Edible is the first listed.
NCT03522324 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03522324 about?
NCT03522324 is a clinical study titled "Pain Research: Innovative Strategies With Marijuana". This study tests the effects of cannabinoid levels in blood on pain relief, inflammation, and cognitive dysfunction in chronic pain patients who choose to use edible cannabis. Over a two-week period, participants use an edible product of their choice. Blood levels of 9-delta-tetrahydrocannabinol (TH...
What is the current status of trial NCT03522324?
This trial is currently completed. The enrollment target is 268 participants. The study started on 2018-06-01. Estimated completion is 2023-10-12.
What interventions are being tested in trial NCT03522324?
The interventions under investigation include: Cannabis Edible (DRUG).
Who is sponsoring clinical trial NCT03522324?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
- NCT05797831 · 268 participants · Phase 2
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- NCT05997381 · 268 participants · NA
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
- NCT06233461 · 268 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI